Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Mar 2026 for BiomX Inc., €787k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Reuven Yeganeh: trading record in brief
Reuven Yeganeh discloses dealings in 2 companies, chiefly BiomX Inc. and Nukkleus Inc. Over a trading history stretching from 16 December 2024 to 16 March 2026, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 18 March 2026, reports a transaction of €787k in BiomX Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Reuven Yeganeh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
450,000 shares@ US$2.0060.4% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-26-031016:0
300,000 shares@ US$2.0039.6% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-26-027698:0
10,000 shares0Common Stock, $0.0001 par value per shareSEC:0001213900-25-113013:0
10,000 shares@ US$1.39100.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001213900-24-111166:0
4 of 4 declarations
